Intercure (INCR) director reports 15,000 share options at $3.10 strike
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Intercure Ltd. director Granot Alon Shmuel reported an initial holding of share options giving the right to buy 15,000 Ordinary Shares. These options carry an exercise price of $3.10 per share, based on converting a NIS 9.50 price at an exchange rate of NIS 3.06 to $1.00. The options were granted on September 5, 2024, vest quarterly over four years from the grant date, and expire on September 5, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Granot Alon Shmuel
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share options (right to buy) | -- | -- | -- |
Holdings After Transaction:
Share options (right to buy) — 15,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Underlying option shares: 15,000 shares
Exercise price (USD): $3.10 per share
Exercise price (NIS): NIS 9.50 per share
+3 more
6 metrics
Underlying option shares
15,000 shares
Ordinary Shares underlying director options
Exercise price (USD)
$3.10 per share
Converted for Form 3 disclosure
Exercise price (NIS)
NIS 9.50 per share
Original option grant exercise price
FX rate used
NIS 3.06 = $1.00
Conversion rate as of April 14, 2026
Option term
4 years vesting
Quarterly vesting from September 5, 2024
Option expiration
September 5, 2028
Expiration date of share options
Key Terms
Share options (right to buy), exercise price, vesting, Form 3
4 terms
exercise price financial
"the current exercise price is NIS 9.50 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The options vest on a quarterly basis over four years"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 3 regulatory
"For purposes of this Form 3, the exercise price has been converted"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
FAQ
What insider position does Granot Alon Shmuel report on Intercure (INCR) Form 3?
Granot Alon Shmuel reports holding share options to buy 15,000 Intercure Ordinary Shares. These options represent a derivative position, not current share ownership, and establish his baseline equity-linked holdings as a director in the company’s public disclosures.
What is the exercise price of Granot Alon Shmuel’s Intercure (INCR) options?
The options have an exercise price of NIS 9.50 per share, converted to $3.10 for Form 3 using an exchange rate of NIS 3.06 to $1.00. This is the price he must pay per share if he chooses to exercise.
When do Granot Alon Shmuel’s Intercure (INCR) options vest and expire?
The options were granted on September 5, 2024, and vest on a quarterly schedule over four years from that date. They expire on September 5, 2028, giving a defined window during which they can be exercised before they lapse.
Does the Intercure (INCR) Form 3 show any recent insider buying or selling?
The Form 3 shows a holding entry for existing share options rather than a new purchase or sale. It establishes Granot Alon Shmuel’s current derivative position in Intercure but does not report open-market buying, selling, or recent transactional activity.